Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-006481
Filing Date
2017-10-20
Accepted
2017-10-20 17:03:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2233589z424b5.htm 424B5 310070
2 G179565.JPG g179565.jpg GRAPHIC 18165
3 G753784.JPG g753784.jpg GRAPHIC 94372
  Complete submission text file 0001047469-17-006481.txt   466294
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214859 | Film No.: 171147519
SIC: 2834 Pharmaceutical Preparations